Literature DB >> 11161432

MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.

J B Domachowske1, C A Bonville, J L Gao, P M Murphy, A J Easton, H F Rosenberg.   

Abstract

The intent of this study was to compare the cellular and biochemical inflammatory responses of mice infected with the paramyxovirus pathogens respiratory syncytial virus (RSV) and pneumonia virus of mice (PVM). Although RSV is not a natural pathogen of mice, it has been used extensively in mouse models of the human disease, as a limited respiratory infection can be established via intranasal inoculation of virus at high titer. In earlier work, we found that acute infection with the natural rodent pathogen, PVM, elicited a rapid and sustained pulmonary inflammatory response (peak, 1.7 x 10(6) leukocytes/ml BAL fluid) that was dependent on both local production of MIP-1alpha and signaling via its receptor, CCR1. We find here that MIP-1alpha is also produced in response to RSV, although relatively few leukocytes (<200 ml BAL fluid) are recruited to the lungs in response. Further experiments with CCR1-deficient mice confirm the finding that although MIP-1alpha is produced in response to RSV infection, leukocytes do not respond via this pathway. Among the explanations for these findings, we propose that there are other, as yet to be identified proinflammatory mediators elicited in response to PVM (but not in response to RSV) that serve to prime the leukocytes in vivo, thus enabling them to respond to MIP-1alpha signaling via CCR1. Furthermore, the differences in disease pathogenesis seen in response to each of these pneumovirus infections in mice raise questions regarding the extent to which primary RSV infection in mice can be used as a model of primary RSV infection in humans. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11161432     DOI: 10.1006/cimm.2000.1730

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  21 in total

1.  Elevated chemokine responses are maintained in lungs after clearance of viral infection.

Authors:  Jason B Weinberg; Mary L Lutzke; Stacey Efstathiou; Steven L Kunkel; Rosemary Rochford
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.

Authors:  Nina Ank; Klavs Petersen; Lene Malmgaard; Søren C Mogensen; Søren R Paludan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Gammaherpesvirus-induced lung pathology is altered in the absence of macrophages.

Authors:  J M Cadillac; R E Sigler; J B Weinberg; M L Lutzke; R Rochford
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

4.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  Acute respiratory infection with mouse adenovirus type 1.

Authors:  Jason B Weinberg; Gregory S Stempfle; John E Wilkinson; John G Younger; Katherine R Spindler
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

6.  IL-21 promotes the pathologic immune response to pneumovirus infection.

Authors:  Rosanne Spolski; Lu Wang; Chi-Keung Wan; Cynthia A Bonville; Joseph B Domachowske; Hyoung-Pyo Kim; Zuxi Yu; Warren J Leonard
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

Review 7.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors:  Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy.

Authors:  Dennis M Lindell; Thomas E Lane; Nicholas W Lukacs
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

Review 10.  Insights from natural host-parasite interactions: the Drosophila model.

Authors:  Erin S Keebaugh; Todd A Schlenke
Journal:  Dev Comp Immunol       Date:  2013-06-10       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.